Fujifilm says significantly boosts capacity for COVID-19 treatment Avigan

Japan's Fujifilm Holdings Corp said it has expanded manufacturing capacity to "significantly increase" production of its anti-flu drug Avigan that is being tested as a treatment for COVID-19.